文献速递神经介入DSAMR

血流导向装置治疗脑血泡样动脉瘤

Flow diverter treatment of cerebral blister aneurysms.
PubMed 文献 · Neuroradiology · 2017-10-18

回顾性分析本三级医疗中心8例破裂血泡样动脉瘤患者接受血流导向装置治疗,中位年龄49岁,最常见位于颈内动脉床突上段,1年随访6/7例(85.7%)预后良好,最新血管造影或MRI显示6/8例(75%)完全闭塞,无再破裂、再治疗或复发。作者认为血流导向装置可能是血泡样动脉瘤可行的治疗选择,但长期疗效尚不清楚。

要点

  • 破裂血泡样动脉瘤行血流导向装置治疗,最新影像随访6/8例(75%)完全闭塞(中位8个月)。
  • 1年随访6/7例(85.7%)改良Rankin评分为0-2分,无再破裂、再治疗或复发。
  • 所有患者均接受双联抗血小板治疗,急性破裂期使用双联抗血小板治疗可能具有挑战性。

核心结论

  • 血流导向装置可能是血泡样动脉瘤可行的治疗选择,具有高闭塞率和低再治疗率及良好的中期结局,但长期疗效尚不清楚。

研究设计与样本

  • 回顾性研究,纳入本三级医疗中心8例接受血流导向装置治疗的破裂血泡样动脉瘤患者,收集中位年龄49岁(四分位距42-57)、5例女性(62.5%)、最常见位于颈内动脉床突上段、中位Hunt-Hess评分2分(四分位距1.7-3.2)、所有患者均接受双联抗血小板治疗。

关键影像表现/征象

  • 血泡样动脉瘤为小型、易碎、宽基底动脉瘤,再破裂风险高。
  • 最常见部位为颈内动脉床突上段。
  • 最新血管造影(7例)或MRI(1例)显示6/8例(75%)动脉瘤完全闭塞,中位时间8个月。

诊断标准与关键数值

  • 良好临床结局定义为改良Rankin评分0-2分,1年随访时6/7例(85.7%)达到。
  • 完全闭塞定义为最新血管造影(7例)或MRI(1例)显示动脉瘤完全闭塞,6/8例(75%)达到,中位随访8个月。

临床应用与阅片要点

  • 血流导向装置治疗破裂血泡样动脉瘤可获得较高闭塞率(6/8例,75%)和低再治疗率,无再破裂或复发。
  • 急性破裂期使用双联抗血小板治疗可能具有挑战性。
  • 长期疗效尚不清楚。

局限性

  • 长期疗效尚不清楚。
  • 急性破裂期双联抗血小板治疗可能具有挑战性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Blood blister-like aneurysms (BBA) are small, friable, broad-based aneurysms that represent high risk for rerupture. Treatment of BBA is challenging, and may include surgical wrapping, clipping, multiple overlapping stents, and/or coiling. Flow diversion is a rapidly evolving treatment strategy for intracranial aneurysms, but the evidence for its use in cases of BBA is scarce.

METHODS: A retrospective review of flow-diverter-treated, ruptured BBA cases at our tertiary care institution was undertaken. Clinical, imaging, procedural, and mid-term follow-up data on the patients were collected.

RESULTS: Eight patients underwent flow-diverter stent treatment for ruptured BBA. Median age at time of treatment was 49 years (interquartile range [IQR] 42-57) with five females (62.5%). The most common location of the BBA was the supraclinoid segment of the internal carotid artery. The median Hunt-Hess score was 2 (IQR 1.7-3.2). All patients were treated with dual anti-platelet therapy. Good clinical outcomes (modified Rankin score 0-2) were seen in 6/7 (85.7%) patients with available follow-up at 1 year. Complete occlusion of the aneurysm on latest angiogram (7) or MRI (1) was seen in 6/8 (75%) patients (at a median of 8 months). No patient had rerupture, retreatment, or recurrence of the aneurysm.

CONCLUSION: Flow-diverter stents may be a feasible treatment option for BBAs. They offer high occlusion and low retreatment rates with good mid-term outcomes, but the long-term efficacy remains unknown. Also, dual anti-platelet therapy in the acute ruptured setting can be challenging.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Cerejo R, Bain M, John S, et al. Flow diverter treatment of cerebral blister aneurysms. Neuroradiology. 2017. PMID: 29046918. doi:10.1007/s00234-017-1936-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。